Kala Pharmaceuticals
KALA
$6.75
Share price
-2.81%
Change (1 day)
-55.53%
Change (1 year)
Categories
Earnings for Kala Pharmaceuticals (KALA)
Earnings in 2023 (TTM): -$42.2 M
According to Kala Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$42.2 M. In 2022 the company made an earning of -$44.83 M an increase over its 2021 earnings that were of -$0.15 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Kala Pharmaceuticals from 2016 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$42.2 M | -5.85% |
| 2022 | -$44.83 M | -68.57% |
| 2021 | -$0.15 B | 36.69% |
| 2020 | -$0.11 B | 10.58% |
| 2019 | -$94.35 M | 41.37% |
| 2018 | -$66.74 M | 58.11% |
| 2017 | -$42.21 M | 27.27% |
| 2016 | -$33.17 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | 336.79% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -55.10% | 🇺🇸 USA |